The Comparison of the Effect of Adding Empagliflozin to the Medication Regimen on Peripheral Neuropathy in Patients With Type <scp>II</scp> Diabetes: A Double Blind Randomised Clinical Trial
Empagliflozin reduces blood glucose levels and improves kidney filtration function. It also enhances clinical symptoms and nerve conduction velocity in patients with diabetic neuropathy.
Authors
- Mohammadreza Vafaeinasab
- Akram Ghadiri‐Anari (ORCID: https://orcid.org/0000-0002-9430-4894)
- Reyhaneh Azizi (ORCID: https://orcid.org/0000-0002-0996-045X)
- Marzieh Zare Bidaki
- Fatemeh Mirzaei Malekabad (ORCID: https://orcid.org/0009-0005-9453-4859)
- Amidodin Khatibi (ORCID: https://orcid.org/0000-0003-1774-3161)
Institutions
- Shahid Sadoughi University of Medical Sciences and Health Services (IR)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/edm2.70128
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29